60 Tabs — 1200 mcg
Uptravi (selexipag) is a medication used to treat pulmonary arterial hypertension (PAH) to improve exercise capacity and delay clinical worsening. It works by keeping blood vessels open, helping to reduce high blood pressure in the lungs.
Uptravi is a prescription medicine used to treat pulmonary arterial hypertension (PAH). It belongs to a class of medicines called endothelin receptor antagonists (ERAs). Uptravi works by blocking the action of endothelin, a naturally occurring substance in the body that causes blood vessels to narrow. This can help improve symptoms of PAH and help slow down the progression of the disease. Uptravi is usually taken once a day with or without food. Common side effects include headache, nausea, and dizziness.
Uptravi can also cause serious side effects, including liver damage, low blood pressure, and an increased risk of infection. Before taking Uptravi, be sure to tell your doctor about any other medications you are taking and any medical conditions you have.